statistiche ricercatore

TOSI, GIOVANNA

Distribuzione geografica

Continente	#
NA - Nord America	8.239
EU - Europa	7.964
AS - Asia	1.700
Continente sconosciuto - Info sul continente non disponibili	8
OC - Oceania	3
AF - Africa	2
SA - Sud America	2
Totale	17.918

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	8.157
IT - Italia	4.299
UA - Ucraina	1.553
TR - Turchia	637
VN - Vietnam	582
SE - Svezia	560
DE - Germania	501
CN - Cina	423
FI - Finlandia	394
IE - Irlanda	297
GB - Regno Unito	150
FR - Francia	106
CA - Canada	82
RU - Federazione Russa	46
BE - Belgio	28
JP - Giappone	21
IN - India	20
EU - Europa	8
IR - Iran	7
NL - Olanda	7
CZ - Repubblica Ceca	5
CH - Svizzera	4
BY - Bielorussia	2
HK - Hong Kong	2
HR - Croazia	2
KR - Corea	2
NZ - Nuova Zelanda	2
PK - Pakistan	2
RS - Serbia	2
AT - Austria	1
AU - Australia	1
BR - Brasile	1
DK - Danimarca	1
DZ - Algeria	1
EG - Egitto	1
ES - Italia	1
GR - Grecia	1
IL - Israele	1
ME - Montenegro	1
MK - Macedonia	1
NO - Norvegia	1
PH - Filippine	1
PL - Polonia	1
SG - Singapore	1
TW - Taiwan	1
VE - Venezuela	1
Totale	17.918

Salva come PNG Salva come JPEG

Città	#
Milan	3.337
Jacksonville	1.191
Fairfield	928
Chandler	783
Woodbridge	609
Ashburn	540
Wilmington	428
Ann Arbor	424
Izmir	405
Princeton	398
Houston	392
Seattle	384
Dearborn	366
Nyköping	297
Dublin	295
Cambridge	287
Dong Ket	268
Rome	230
Beijing	168
San Mateo	138
Como	91
San Diego	76
Toronto	76
Ogden	69
New York	61
Düsseldorf	45
Boardman	34
Hefei	34
Verona	33
Nanjing	28
Brussels	27
Norwalk	25
Helsinki	23
Pune	20
Tokyo	20
Kunming	19
Los Angeles	18
Falls Church	17
London	17
Guangzhou	16
Washington	16
Jinan	15
Phoenix	13
Fuzhou	11
Kocaeli	9
Kilburn	8
Nanchang	8
Frankfurt am Main	7
Hangzhou	7
Hebei	7
Tehran	7
Xian	7
Auburn Hills	6
Changsha	6
Wuhan	6
Chongqing	5
Edinburgh	5
Perugia	5
Ponte Lambro	5
Berlin	4
Brno	4
Chengdu	4
Indiana	4
Lausanne	4
Shenyang	4
Zhengzhou	4
Aprilia	3
Baotou	3
Chiswick	3
Costa Mesa	3
Florence	3
Hounslow	3
Huzhou	3
Islington	3
Monza	3
Prescot	3
Quzhou	3
Redmond	3
San Francisco	3
Ürümqi	3
Acton	2
Amsterdam	2
Belgrade	2
Birmingham	2
Fiesole	2
Guiyang	2
Gumi	2
Hong Kong	2
Jinhua	2
Leawood	2
Mariano Comense	2
Minsk	2
Montreal	2
Rozzano	2
Shaoxing	2
Stanford	2
Taiyuan	2
Turin	2
Wenzhou	2
Wilnsdorf	2
Totale	12.880

Salva come PNG Salva come JPEG

Nome	#
CIITA-driven MHC class ii expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells	181
Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1	177
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)	170
Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: A critical issue for triggering protective immunity and re-orienting the tumor microenvironment toward an anti-tumor state	165
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	164
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells	164
Picosecond-resolved FRET on non-amplified DNA for identifying individuals genetically susceptible to type-1 diabetes	156
The MHC class II transactivator: prey and hunter in infectious diseases	154
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	150
Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression.	149
The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1	146
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis	144
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells	143
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators	143
Typing of a polymorphic human gene conferring susceptibility to insulin-dependent diabetes mellitus by picosecond-resolved FRET on non-purified/non-amplified genomic DNA	142
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.	141
A girl with Diabetes and severe Combined Immunodeficiency from Adenosine Deaminase Deficiency	141
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	139
The MHC class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation.	136
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication	135
Adequate Antigen Availability: A Key Issue for Novel Approaches to Tumor Vaccination and Tumor Immunotherapy	133
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory	132
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication	130
Distinct regulation of HLA class II and class I cell surface expression in THP-1 macrophage cell line after bacterial phagocytosis	127
MHC class II gene regulation: some historical considerations on a still ontogenetic and phylogenetic puzzle	126
Assessment of the DQB1-DQA1 complete genotype allows best prediction for IDDM	126
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	126
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells	126
HLA-DQ genotype in early onset insulin dependent diabetes mellitus	125
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1.	125
MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to and affecting Tax-2 intracellular localization	122
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma	122
Time-Resolved Förster Resonance Energy Transfer Analysis of Single-Nucleotide Polymorphisms: Towards Molecular Typing of Genes on Non-Purified and Non-PCR-Amplified DNA	121
Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR	120
Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters	120
MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?	120
New approaches of cancer vaccination and cancer immunotherapy based on the optimal stimulation of tumor-specific, MHC class II-restricted CD4+ T helper cells	120
Insight into the molecular mechanism of CIITA-mediated inhibition of HIV-1 and HTLV transactivators	119
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory	118
Molecular and Cellular Correlates of the CIITA-Mediated Inhibition of HTLV-2 Tax-2 Transactivator Function Resulting in Loss of Viral Replication.	118
The MHC-II transactivator CIITA inhibits Tat-mediated HIV-1 LTR transactivation and virus replication in human U937 monocytic cells	117
Role of the HLA-DQ genotype in IDDM susceptibility	117
Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes	117
Autoimmunità e Malattie Autoimmuni	115
Tumor Immunology meets Immunology: Modified cancer cells as professional APC for priming naÃ¯ve tumor-specific CD4+ T cells	115
The complex interplay of the DQB1 and DQA1 loci in the generation of the susceptible and protective phenotype for Insulin-Dependent Diabetes Mellitus	115
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1	114
Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers	113
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-kappa B by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein	113
The MHC class II transactivator CIITA inhibits the persistent activation of NF-kB by Human T cell Lymphotropic Virus type-1 Tax-1 oncoprotein	112
Expression of MHC class I and class II antigens in pancreatic adenocarcinomas	110
The MHC Class II transactivator, CIITA,is a viral restriction factor for human oncogenic retroviruses	110
Tax-1-mediated HTLV-1 replication and NF-kB activation is inhibited by the MHC-II transactivator CIITA	110
HLA-DQB1 typing of north east italian IDDM patients using amplified DNA, oligonucleotide probes and a rapid DNA-Enzyme Immunoassay (DEIA)	109
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic Virus Type 1	109
HIV-1 Tat mutants in the cysteine-rich region down-regulate HLA class II expression in T lymphocytic and macrophage cell lines	109
HTLV-2 Tax-2 transactivator increases the expression and the function of its inhibitor CIITA, the master regulator of HLA-II gene transcription	108
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1b molecules after bacterial phagocytosis	107
Inhibition of Human T-Cell Leukemia virus type 2 (HTLV-2) replication by the suppressive action of CIITA and NF-Y	106
The MHC-II transactivator CIITA is a viral restriction factor against HIV-1 replication	106
Tax-1-mediated NF-kB activation is inhibited by the MHC-II transactivator CIITA	106
Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines	105
Molecular typing of polymorphic genes by time-resolved fluorescence resonance energy transfer	104
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1B molecules after mycobacterial phagocytosis	102
Adequate Antigen Availability (AAA) in antitumor immunity: Definition and consequences for novel strategies of tumor prevention and antitumor treatment	102
Tat protein is an HIV-1 encoded SS-chemochine homolog that promotes migrationand upregulates CCR3 on human FceRI+ cells	101
The constitutive activation of NF-kB by HTLV-1 Tax-1 oncoprotein is inhibited by the MHC class II transactivator CIITA	101
Human T-cell leukemia virus type II directly acts on CD34+ hematopoietic precursors by increasing their survival potential. Envelope associated HLA class II molecules reverse this effect	99
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic Virus Type 1	99
Tumor treatment by TNF-alpha targeted to tumor vessels and melphalan induces strong adaptive immune response, protection from tumor growth and anti-tumor memory.	98
Apparente dissociazione tra fenotipo DR e genotipo MHC di classe II in IDDM	97
A dual defensive role of CIITA against retroviral infections	95
A new strategy of tumor vaccination based on mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA	95
CIITA dependent MHC class II IA expression in tumor cells triggers CD4 T cell protective and long lasting antitumor immunity	95
Associazione tra genotipo HLA-DQ e suscettibilità al Diabete insulino-Dipendente	94
Host-retrovirus interaction: role of CIITA in the inhibition of HTLV-1 replication and oncogenic potential	92
Therapy-induced antitumor vaccination by targeting TNFa to tumor vessels in combination with melphalan	91
The MHC class II transactivator (CIITA): a "physiologic" drug against HIV-1 replication	91
Evidence for a specific post- transcriptional mechanism controlling the expression of HLA-DQ, but not DR and DP molecules	90
TPA-mediated down-regulation of MHC class II gene expression in human macrophage precursors by destabilization of the MHC-II transactivator (CIITA) mRNA	90
Control of mammary adenocarcinoma growth in vivo by gene therapy with the MHC class II transactivator CIITA	88
Efficient antigen presentation and T cell activation by MHC class II molecules of CIITA-transfected epatocarcinoma cells	88
Regulation of HLA antigen expression in HIV infected cells	88
Espressione delle molecole HLA di classe II in cellule di epatocarcinoma classe II negative dopo trasfezione del transattivatore CIITA. Acquisizione della capacità di processare e presentare l'antigene	86
HTLV-II è mitogenico per i precursori emopoietici CD34+. La presenza di molecole HLA di classe II sull'envelope virale annulla tale effetto	85
CIITA, the Master Regulator of MHC Class II Gene Transcription, Targets the Viral Transactivator Tax-1 to Inhibit HTLV-I Viral Replication and NFKB Activation	84
Reduced expression of the AIR-1 gene product CIITA as the cause of HLA class II down-modulation in normal human macrophages during bacterial phagocytosis	83
HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA. Acquisition of antigen processing and presentation capacity.	83
The MHC class II transactivator, CIITA, blocks the transcriptional activity of both HTLV-2 Tax-2 and HTLV-1 Tax-1	83
Regolazione dell'espressione dei geni del Complesso Maggiore di Istocompatibilità HLA e di CD4 in cellule infettate da HIV: effetto di TAT	83
Analysis of microchimerism in thyroid autoimmune diseases	83
CIITA reduced transcription as the cause of HLA class II down-modulation in human macrophages during bacterial phagocytosis	83
HTLV-II Tax-2 increases the cell surface expression of HLA-II molecules by acting at the level of CIITA, the master regulator of HLA-II transcription	83
Distinct subcellular localization of HTLV-1 HBZ oncoprotein in the ATL leukemic and HAM/TSP patients.	83
Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalan	82
The HLA class II transcriptional activator (CIITA) blocks the function of HIV-1 Tat and inhibits viral replication	82
Block of Stat-1 activation in macrophages, undergoing bacterial phagocytosis causes CIITA reduced transcription and consequent impaired antigen presentation	81
The AIR-1 locus encoded HLA class II transcriptional activator (CIITA) inhibits HIV-1 replication by blocking the function of HIV-1 Tat	81
CIITA blocks the function of HIV-1 Tat by competing for cyclin T1 and inhibits viral replication	81
Cellular and molecular aspects of immune response relevant to autoimmune diseases	81
Totale	11.366

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	58.512
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	58.512

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	2.964	118	72	117	502	156	340	476	400	211	292	44	236
2020/2021	2.667	28	282	81	265	62	272	83	287	431	102	242	532
2021/2022	1.700	211	223	152	133	42	48	57	123	83	222	159	247
2022/2023	2.159	252	86	120	258	159	493	0	292	312	63	69	55
2023/2024	4.884	816	801	919	824	877	310	50	40	155	20	9	63
2024/2025	6	6	0	0	0	0	0	0	0	0	0	0	0
Totale													17.984